Is Your Child's Allowance Undermining Your Retirement?
The $1,000 Challenge, Part 9: Nibbling Away at the Family Food Bills
The Benefits of Filing Your Taxes Early
After Market: China and Russia Put Stocks in the Red
Alexion price target raised to $199 from $175 at RW Baird
Celldex Therapeutics Is Shutting Down CDX-1135: What Does It Mean?
Stocks Off Lows In Afternoon; Facebook Hits New High
Oppenheimer Top Stocks to Buy as Bull Market Turns Five Years Old
Alexion Pharma (ALXN) Boosts FY14 EPS, Revs Outlook
Alexion Revises Upward 2014 Financial Guidance for Revenues and non-GAAP EPS
Collaborations, Conferences, and Recognitions - Analyst Notes on Illumina, Alexion, Medtronic, Sirona, and NPS Pharmaceuticals
Alexion Pharm (ALXN) Announces Positive NICE Assessment of Eculizumab; Still Has Concerns
British Watchdog Wants U.S. Biotech Alexion Pharmaceuticals Inc. To Justify Cost Of Drug
NICE Seeks Clarification From Alexion On High Cost For Rare Blood Disorder Drug